| __timestamp | Dr. Reddy's Laboratories Limited | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 7461000 |
| Thursday, January 1, 2015 | 42585000000 | 11960000 |
| Friday, January 1, 2016 | 45702000000 | 13108000 |
| Sunday, January 1, 2017 | 46372000000 | 17501000 |
| Monday, January 1, 2018 | 46910000000 | 22472000 |
| Tuesday, January 1, 2019 | 48890000000 | 24286000 |
| Wednesday, January 1, 2020 | 50129000000 | 29689000 |
| Friday, January 1, 2021 | 54559000000 | 38837000 |
| Saturday, January 1, 2022 | 62081000000 | 47489000 |
| Sunday, January 1, 2023 | 105931000000 | 53379000 |
| Monday, January 1, 2024 | 77201000000 |
Cracking the code
In the competitive landscape of pharmaceuticals and biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Dr. Reddy's Laboratories Limited and Xencor, Inc. offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has seen its SG&A expenses grow by approximately 173%, peaking in 2023. In contrast, Xencor's expenses have increased by about 615% over the same period, albeit from a much smaller base. This disparity highlights the different scales and strategies of these companies. While Dr. Reddy's operates on a global scale, Xencor, a smaller biotech firm, is in a growth phase, investing heavily in research and development. The data for 2024 is incomplete, but the trend suggests that both companies are navigating their financial strategies in unique ways, reflecting their distinct market positions and growth trajectories.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Xencor, Inc.
Sanofi and Xencor, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xencor, Inc.
Breaking Down SG&A Expenses: Incyte Corporation vs Xencor, Inc.
Intra-Cellular Therapies, Inc. vs Xencor, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Ascendis Pharma A/S vs Xencor, Inc. Trends and Insights
Axsome Therapeutics, Inc. or Xencor, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Xencor, Inc.